IP Library Granted Patent US 9,080,201
Granted Patent B2
US 9,080,201 · App. 14/002,816 · Granted Jul 14, 2015

Method for measuring cholesterol in HDL subfraction, and reagents and kit therefor

Inventors: Yuki Katayama (Sunto-gun, JP); Hiroyuki Sugiuchi (Kumamoto, JP); Kazumi Matsushima (Kumamoto, JP)
Assignees: KYOWA MEDEX CO., LTD.; KUMAMOTO HEALTH SCIENCE UNIVERSITY
C12Q1/60G01N33/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,080,201
App. No.
14/002,816
Granted
Jul 14, 2015
Kind
B2
Abstract

The present invention provides a method for simply and precisely measuring cholesterol in an HDL subfraction contained in a sample. This is a method for measuring cholesterol in HDL3 contained in a sample, which comprises reacting a sample with (1) a combination of a cholesterol ester hydrolase and a cholesterol oxidase or (2) a combination of a cholesterol ester hydrolase, an oxidized coenzyme and a cholesterol dehydrogenase in an aqueous medium containing: (a) a divalent metal salt; (b) an alkali metal salt selected from the group consisting of a sulfate, a nitrate, a carbonate, an acetate and a halide; and (c) dextran sulfate or a salt thereof, and measuring a substance formed or consumed in the reaction without separating and removing lipoproteins other than HDL3.

Claims (13)

1. A method for determining cholesterol in high-density lipoprotein 3 (HDL3) contained in a sample, which comprises

reacting, in an aqueous medium containing (a) a divalent metal salt, (b) an alkali metal sulfate, and (c) dextran sulfate or a salt thereof, the sample with (1) a combination of a cholesterol ester hydrolase and a cholesterol oxidase or (2) a combination of a cholesterol ester hydrolase, an oxidized coenzyme and a cholesterol dehydrogenase; wherein the concentration of alkali metal ions derived from the alkali metal sulfate in the reaction solution is 5 to 21 mmol/L;

measuring a substance formed or consumed in the reaction;

correlating a calibration curve indicating a relationship between a concentration of cholesterol in HDL3 and an information amount derived from the substance formed or consumed with the measurement value of the substance formed or consumed; and

determining the concentration of cholesterol in HDL3 contained in the sample, wherein

the method is carried out without separating and removing lipoproteins other than HDL3 from the sample.

2. The method according to claim 1 , wherein the divalent metal salt is a magnesium salt or a calcium salt.

3. The method according to claim 2 , wherein the concentration of the dextran sulfate or a salt thereof in the reaction solution is 0.75 to 2.6 g/L.

4. The method according to claim 1 , wherein the concentration of divalent metal ions derived from the divalent metal salt in the reaction solution is 12 to 20 mmol/L.

5. A method for determining cholesterol in high-density lipoprotein 2 (HDL2) contained in a sample, which comprises the following steps:

(1) a step of measuring cholesterol in a high-density lipoprotein (HDL) contained in the sample;

(2) a step of measuring cholesterol in HDL3 contained in the sample by the method according to claim 4 ; and

(3) a step of subtracting a measurement value obtained by the measurement in the step (2) from a measurement value obtained by the measurement in the step (1).

Assignments (4)
CHANGE OF NAME Recorded Sep 23, 2025
From: KYOWA MEDEX CO., LTD.
To: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
Reel/Frame 072925/0508 →
CHANGE OF NAME Recorded Sep 23, 2025
From: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
To: MINARIS MEDICAL CO., LTD.
Reel/Frame 072925/0657 →
CHANGE OF NAME Recorded Sep 23, 2025
From: MINARIS MEDICAL CO., LTD.
To: CANON MEDICAL DIAGNOSTICS CORPORATION
Reel/Frame 072925/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2013
From: KATAYAMA, YUKI; SUGIUCHI, HIROYUKI; MATSUSHIMA, KAZUMI
To: KYOWA MEDEX CO., LTD.; KUMAMOTO HEALTH SCIENCE UNIVERSITY
Reel/Frame 031127/0167 →
Priority Claims (1)
JP 2011-057959 · Mar 16, 2011 · national
Continuity (1)
Related Publication 20130344518A1 · Dec 26, 2013